Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News electroCore, Inc. ECOR

electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company. It provides non-invasive vagus nerve stimulation (nVNS) technology platform. The Company’s product categories include Handheld, personal use medical devices for the management and treatment of certain medical conditions such as primary headache, and Handheld, personal use consumer products utilizing nVNS... see more

Recent & Breaking News (NDAQ:ECOR)

TAC-STIM(TM) Non-Invasive Vagal Nerve Stimulation Selected for Inclusion in the Air Force Research Laboratories Real-Time Assessing and Augmenting Cognitive Performance in Extreme Environments Project

GlobeNewswire June 27, 2023

electroCore to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC

GlobeNewswire June 14, 2023

electroCore Announces Poster to be Presented at the American Headache Society's 65th Annual Scientific Meeting

GlobeNewswire June 13, 2023

electroCore, Inc. Announces Departure of JP Errico from the Board of Directors

GlobeNewswire May 26, 2023

electroCore to Participate at 13th Annual LD Micro Invitational XIII

GlobeNewswire May 23, 2023

electroCore Announces First Quarter 2023 Financial Results

GlobeNewswire May 3, 2023

electroCore to Participate at Annual Aegis Virtual Conference

GlobeNewswire May 1, 2023

National Institutes of Health Awards Grant for Pivotal Clinical Trial of gammaCore(TM) (nVNS) in Patients with Opioid Use Disorders

GlobeNewswire April 26, 2023

Study Presented at 75th Annual Meeting of the American Academy of Neurology Demonstrates that gammaCore (nVNS) Can Accelerate Foreign Language Learning

GlobeNewswire April 24, 2023

electroCore to Announce First Quarter Financial Results on Wednesday, May 3

GlobeNewswire April 19, 2023

electroCore Provides Select First Quarter 2023 Financial Guidance

GlobeNewswire April 17, 2023

electroCore Expands Intellectual Patent Portfolio for nVNS Technology

GlobeNewswire April 12, 2023

electroCore Announces Remittance of Annual License Fee from Teijin for Certain Exclusive Rights in Japan

GlobeNewswire April 11, 2023

electroCore, Inc. Announces Product Registration in Indonesia, Malaysia and South Africa

GlobeNewswire April 6, 2023

electroCore, Inc. Announces gammaCore Non-Invasive Vagus Nerve Stimulator Available Through the Carrick Institute

GlobeNewswire April 4, 2023

electroCore Reports Results of Pre-Clinical Trial in a Model of Traumatic Brain Injury

GlobeNewswire March 23, 2023

electroCore's Truvaga Users Reported Improved Stress, Anxiety, Sleep, Energy and Mood in Recent Focus Group Study

GlobeNewswire March 21, 2023

electroCore Affirms No Direct Exposure to Silicon Valley Bank, Silvergate Bank, or Signature Bank

GlobeNewswire March 14, 2023

electroCore Announces Poster to be Presented at the 2023 American Academy of Neurology Annual Scientific Meeting

GlobeNewswire March 13, 2023

electroCore to Participate at 35th Annual Roth Conference

GlobeNewswire March 9, 2023